top of page
Biopharma Leaders Prepare to Navigate Medicare’s New Negotiating Power

A clearer understanding of the Inflation Reduction Act’s implications is needed for manufacturers to plot a successful course forward....

Will your clinical trials deliver the leverage you need with payers?

The quality of the clinical evidence will forever be the cornerstone of every payer engagement. Poor integration of payer insights into...

Exclusive Agreement with the National Association of Specialty Pharmacy (NASP)

Formulary Insights transformed the payer market research landscape providing a better way to capture and deliver accurate payer insights.

3 Reasons US Payers Will Make 2021 a Banner Year for Biosimilars

Following a year which saw a 143% increase in launched biosimilars in the US, three reasons why payers will drive adoption further in 2021.

A Better Path to Payer Insights

Payers have transformed the competitive marketplace, and biopharma companies need to regain their role as the authority on their products.

For Payer Research, High Stakes are the Mother of All Invention

As payers increasingly stifle new drug launches, investors in biopharmaceutical companies pursue better sources of insights.


So many market access puzzles to solve and so little time.
That’s why our agile approach works.

bottom of page